Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer

INTRODUCTION: The phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in cancer cells through numerous mutations and epigenetic changes. The recent development of inhibitors targeting different components of the PI3K pathway may represent a valuable treatment alternative. However, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Moestue, Siver A, Dam, Cornelia G, Gorad, Saurabh S, Kristian, Alexandr, Bofin, Anna, Mælandsmo, Gunhild M, Engebråten, Olav, Gribbestad, Ingrid S, Bjørkøy, Geir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672699/
https://www.ncbi.nlm.nih.gov/pubmed/23448424
http://dx.doi.org/10.1186/bcr3391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672699/
https://www.ncbi.nlm.nih.gov/pubmed/23448424
http://dx.doi.org/10.1186/bcr3391

Ejemplares similares